Vigilare Wealth Management’s KALA BIO KALA Stock Holding History

Vigilare Wealth Management’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8	Closed	-$127K	–	213
2021 Q1	$127K	Buy	+8	New	+$156K	0.09%	189

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vigilare Wealth Management's KALA Position: Q2 2021 in Review

Vigilare Wealth Management sold out of KALA BIO (KALA) in Q2 2021, closing a stake of 8 shares — an estimated $127K sold.

Vigilare Wealth Management first reported a position in KALA in Q1 2021 and held it in 1 quarter. The position peaked at $127K in Q1 2021. 97 funds tracked by Wall St. Rank hold KALA as of Q2 2021.

Vigilare Wealth Management reported no remaining KALA BIO position as of Q2 2021 after selling out during the quarter.
Vigilare Wealth Management sold 8 KALA BIO shares in Q2 2021, an estimated $127K.
Vigilare Wealth Management first reported a position in KALA BIO in Q1 2021 and held it in 1 quarter.
Vigilare Wealth Management's KALA BIO position peaked at $127K in Q1 2021.
97 funds tracked by Wall St. Rank held KALA BIO as of Q2 2021.

Based on Vigilare Wealth Management's 13F filing for Q2 2021, filed 16 Jul 2021.